Name
ABTL-0812 Sodium
Drug Entry
alpha-Hydroxylinoleic acid

alpha-Hydroxylinoleic acid is under investigation in clinical trial NCT04431258 (ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study).

Accession Number
DBSALT003376
Structure
Synonyms
ABTL-0812 SODIUM SALT / SODIUM 2-HYDROXYLINOLEATE
UNII
X1840C8161
CAS Number
Not Available
Weight
Average: 318.433
Monoisotopic: 318.21708914
Chemical Formula
C18H31NaO3
InChI Key
VFXKYDDSDQXKLC-NBTZWHCOSA-M
InChI
InChI=1S/C18H32O3.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(19)18(20)21;/h6-7,9-10,17,19H,2-5,8,11-16H2,1H3,(H,20,21);/q;+1/p-1/b7-6-,10-9-;
IUPAC Name
sodium (9Z,12Z)-2-hydroxyoctadeca-9,12-dienoate
SMILES
[Na+].CCCCC\C=C/C\C=C/CCCCCCC(O)C([O-])=O
ChemSpider
64854727
Predicted Properties
PropertyValueSource
logP5.55Chemaxon
pKa (Strongest Acidic)4.29Chemaxon
pKa (Strongest Basic)-3.8Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area60.36 Å2Chemaxon
Rotatable Bond Count14Chemaxon
Refractivity100.85 m3·mol-1Chemaxon
Polarizability36.03 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon